Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Human Genetics|February 7, 2008
Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synucleinGaofeng Wang, Joelle M van der Walt, Gregory Mayhew, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 18, 2006
Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson diseaseSun J Kang, William K Scott, Yi-Ju Li, et al.
American Journal of Clinical Dermatology|June 23, 2019
Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis CouncilBruce Strober, Peter C M van de Kerkhof, Kristina Callis Duffin, et al.
American Journal of Human Genetics|May 4, 2004
Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson diseaseJoelle M van der Walt, Maher A Noureddine, Raja Kittappa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2005
Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigraMaher A Noureddine, Yi-Ju Li, Joelle M van der Walt, et al.
Human Genetics|August 4, 2005
Maternal lineages and Alzheimer disease risk in the Old Order AmishJoelle M van der Walt, William K Scott, Susan Slifer, et al.
Neuroscience Letters|July 6, 2004
Analysis of European mitochondrial haplogroups with Alzheimer disease riskJoelle M van der Walt, Yulia A Dementieva, Eden R Martin, et al.
Dermatology and Therapy|December 23, 2018
Clinical Goals and Barriers to Effective Psoriasis CareBruce E Strober, Joelle M van der Walt, April W Armstrong, et al.
American Journal of Human Genetics|March 6, 2003
Mitochondrial polymorphisms significantly reduce the risk of Parkinson diseaseJoelle M van der Walt, Kristin K Nicodemus, Eden R Martin, et al.
Pageof 1